CS
CSNVY.US Corbion NV ADR
- Market cap
- USD 1.71B
- P/E
- 24.0x
- P/B
- 2.02x
- ROE
- 16.1%
- Dividend yield
- 2.49%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is CSNVY.US undervalued?
Graham numberCSNVY.US trades 46.6% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Corbion NV ADR fundamental analysis
No fundamental analysis for Corbion NV ADR yet.
Corbion NV ADR stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Corbion NV ADR
Corbion N.V. provides lactic acid and derivatives, food preservation solutions, functional ingredient systems, and algae-derived nutritional ingredients in the Netherlands, the United States, Asia, rest of Americas, the rest of Europe, the Middle East, and Africa. It operates in two segments, Functional Ingredients & Solutions, and Health & Nutrition. The company offers antioxidants, fermentation and preservation ingredients, flavors, fortification, functional blends, and la…
Full company profileCorbion NV ADR financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Corbion NV ADR annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 911M | 892M | 897M | 976M | 987M | 1.07B | 1.46B | 1.44B | 1.29B | 1.27B | 2.57B |
| Gross Profit | 277M | 276M | 258M | 199M | 270M | 266M | 324M | 353M | 312M | 330M | 629M |
| Operating Income | 120M | 118M | 89.5M | -2.80M | 104M | 82.0M | 111M | 77.3M | 77.3M | 115M | 172M |
| EBITDA | 175M | 151M | 125M | 120M | 155M | 133M | 194M | 200M | 172M | 197M | 347M |
| Net Income | 104M | 84.6M | 54.3M | 25.8M | 73.1M | 78.3M | 90.0M | 72.9M | 192M | 71.8M | 122M |
| EPS | 1.76 | 1.44 | 0.92 | 0.43 | 1.23 | 1.32 | 1.51 | 1.22 | 3.24 | 1.24 | 2.08 |
| Balance Sheet | |||||||||||
| Total Assets | 843M | 831M | 966M | 1.12B | 1.09B | 1.36B | 1.72B | 1.70B | 1.55B | 1.42B | 1.49B |
| Total Liabilities | 345M | 342M | 446M | 586M | 578M | 807M | 1.10B | 1.06B | 774M | 674M | 733M |
| Shareholders' Equity | 499M | 489M | 520M | 529M | 516M | 554M | 626M | 636M | 773M | 742M | 755M |
| Cash & Short-term Investments | 60.8M | 38.1M | 47.1M | 45.7M | 51.6M | 42.2M | 58.2M | 70.2M | 49.3M | 44.7M | 36.0M |
| Total Debt | 159M | 184M | 250M | 349M | 336M | 503M | 759M | 786M | 509M | 447M | 517M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 123M | 118M | 99.5M | 114M | 109M | 22.4M | 39.0M | 165M | 184M | 155M | 118M |
| Capital Expenditure | 55.5M | 45.5M | 60.1M | 76.2M | 88.9M | 149M | 236M | 149M | 84.2M | 65.5M | 133M |
| Free Cash Flow | 67.1M | 72.2M | 39.4M | 38.2M | 20.1M | -126M | -197M | 16.1M | 99.9M | 89.0M | -15.1M |
| Ratios | |||||||||||
| ROE | 20.8% | 17.3% | 10.4% | 4.9% | 14.2% | 14.1% | 14.4% | 11.5% | 24.9% | 9.7% | 16.1% |
| ROA | 12.3% | 10.2% | 5.6% | 2.3% | 6.7% | 5.8% | 5.2% | 4.3% | 12.4% | 5.1% | 8.2% |
| Net Profit Margin | 11.4% | 9.5% | 6.1% | 2.6% | 7.4% | 7.3% | 6.2% | 5.0% | 14.9% | 5.7% | 4.7% |
| Debt to Equity | 0.32x | 0.38x | 0.48x | 0.66x | 0.65x | 0.91x | 1.21x | 1.23x | 0.66x | 0.60x | 0.68x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Corbion NV ADR dividends
- Dividend yield
- 2.49%
- Forward dividend
- 0.74 USD
- Payout ratio
- 49.7%
- Ex-dividend date
- May 18, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 35.7M | 0.62 | 49.7% |
| 2024 | EUR 41.9M | 0.71 | 21.8% |
| 2023 | EUR 33.1M | 0.55 | 45.4% |
| 2022 | EUR 33.0M | 0.55 | 36.7% |
| 2021 | USD 33.0M | 0.56 | 42.1% |
| 2020 | USD 33.0M | 0.55 | 45.1% |
| 2019 | USD 32.9M | 0.55 | 127.5% |
| 2018 | USD 32.9M | 0.55 | 60.6% |
| 2017 | USD 60.5M | 1.03 | 71.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Corbion NV ADR
Ownership data of Corbion NV ADR is not available yet.
Corbion NV ADR company profile
- Company name
- Corbion NV ADR
- Ticker
- CSNVY.US
- Exchange
- USA Stocks
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 2,363
- Fiscal year end
- December
- Address
- Piet Heinkade 127, Amsterdam, Netherlands, 1019 GM
- Phone
- 31 20 590 6911
- Website
- corbion.com
About Corbion NV ADR
Corbion N.V. provides lactic acid and derivatives, food preservation solutions, functional ingredient systems, and algae-derived nutritional ingredients in the Netherlands, the United States, Asia, rest of Americas, the rest of Europe, the Middle East, and Africa. It operates in two segments, Functional Ingredients & Solutions, and Health & Nutrition. The company offers antioxidants, fermentation and preservation ingredients, flavors, fortification, functional blends, and lactic acid lactates and derivatives; AlgaPrime DHA, an omega-3 sourcing product; AlgaVia which develops foods and beverages with reduced saturated fat content; CALFEED, a dry lactic acid source to boost feed intake for swine or poultry; LAFEED that helps feed intake and digestive health; LAFEED Powder that acts as a preservative and acidulate; PURAC DW, provides an acidifier, preservative, and antimicrobial in teat-dip applications for animals; PURAC Pet food; PURASOLV; and PURASOLV EL. It also provides PURASORB polymers for medical and pharmaceutical industries; PURASOLV solvents; PURALACT B3 for resin and coating performance; personal care products, such as ESTERLAC Emulsifiers and Surfactants, GLUCONAL ZN, PURAC BF/P41, PURAC HiPure 90, PURAC UltraPure, PURACAL PP/USP, PURAMEX ZN, PURASAL MOISTXS, PURASAL NH/COS, PURASAL S/HQ60, and PURASOLV EL; and GLUCONAL, PURAC PF, PURACAL, PURAMEX, and PURASAL S/PF. In addition, the company offers food solutions, including acidification, color retention, decontamination, food safety and preservation, freshness and shelf life, health and nutrition, strengthening conditioning and texturizing, and taste and texture; PURASORB R&D; biochemical specialties solutions comprising solvency, antimicrobial, moisturization, and pharma; and Algae ingredients solutions. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was founded in 1903 and is headquartered in Amsterdam, the Netherlands.
Corbion NV ADR management
8- Mr. Olivier RigaudChairman of the Management Board & CEO · born 1964
- Mr. Peter KaziusCFO & Member of Management Board · born 1972
- Dr. Yves Boland Ph.D.Chief Technology Officer · born 1979
- Mr. Alex SokolowskiHead of Investor Relations
- Sanne VerhoevenHead of Public Affairs & Communication
- Ms. Masha Vis-MertensChief Human Resources Officer · born 1971
- Mr. Ruud PeerboomsChief Commercial Officer · born 1969
- Mr. Oli ArnasonChief Integrated Supply Officer · born 1976